Ad is loading...
CASBF
Price
$3.90
Change
-$0.00 (-0.00%)
Updated
Nov 8 closing price
CHSYF
Price
$0.93
Change
-$0.00 (-0.00%)
Updated
May 1 closing price
Ad is loading...

CASBF vs CHSYF

Header iconCASBF vs CHSYF Comparison
Open Charts CASBF vs CHSYFBanner chart's image
CANSINO BIOLOGICS
Price$3.90
Change-$0.00 (-0.00%)
Volume$1.05K
CapitalizationN/A
China Medical System Holdings
Price$0.93
Change-$0.00 (-0.00%)
Volume$110
CapitalizationN/A
CASBF vs CHSYF Comparison Chart
Loading...
View a ticker or compare two or three
VS
CASBF vs. CHSYF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CASBF is a Hold and CHSYF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CASBF: $3.90 vs. CHSYF: $0.93)
Brand notoriety: CASBF and CHSYF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CASBF: 145% vs. CHSYF: 100%
Market capitalization -- CASBF: $1.92B vs. CHSYF: $4.12B
CASBF [@Pharmaceuticals: Other] is valued at $1.92B. CHSYF’s [@Pharmaceuticals: Other] market capitalization is $4.12B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CASBF’s FA Score shows that 1 FA rating(s) are green whileCHSYF’s FA Score has 1 green FA rating(s).

  • CASBF’s FA Score: 1 green, 4 red.
  • CHSYF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CASBF and CHSYF are a bad buy in the long-term.

Price Growth

CASBF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while CHSYF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
CHSYF($4.12B) has a higher market cap than CASBF($1.92B). CASBF has higher P/E ratio than CHSYF: CASBF (9.30) vs CHSYF (8.13). CASBF YTD gains are higher at: 32.114 vs. CHSYF (-38.689). CHSYF has higher annual earnings (EBITDA): 3.74B vs. CASBF (1.09B). CASBF has more cash in the bank: 7.01B vs. CHSYF (5.25B). CHSYF has less debt than CASBF: CHSYF (1.8B) vs CASBF (2.14B). CHSYF has higher revenues than CASBF: CHSYF (8.94B) vs CASBF (2.87B).
CASBFCHSYFCASBF / CHSYF
Capitalization1.92B4.12B47%
EBITDA1.09B3.74B29%
Gain YTD32.114-38.689-83%
P/E Ratio9.308.13114%
Revenue2.87B8.94B32%
Total Cash7.01B5.25B133%
Total Debt2.14B1.8B118%
FUNDAMENTALS RATINGS
CHSYF: Fundamental Ratings
CHSYF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
34
PRICE GROWTH RATING
1..100
72
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIRRX12.820.03
+0.23%
T. Rowe Price Real Estate I
WFPAX51.26-0.25
-0.49%
Allspring Special Mid Cap Value A
RYAVX79.24-0.41
-0.51%
Rydex S&P MidCap 400 Pure Value H
ISCIX40.12-0.35
-0.86%
Federated Hermes Intl Small-Mid Co IS
SDGTX131.95-2.98
-2.21%
DWS Capital Growth Institutional

CASBF and

Correlation & Price change

A.I.dvisor tells us that CASBF and CRLBF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASBF and CRLBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CASBF
1D Price
Change %
CASBF100%
N/A
CRLBF - CASBF
3%
Poorly correlated
-0.71%
CNTMF - CASBF
2%
Poorly correlated
+3.64%
BUDZ - CASBF
2%
Poorly correlated
-8.42%
CBWTF - CASBF
1%
Poorly correlated
-5.26%
CPHRF - CASBF
0%
Poorly correlated
-0.51%
More

CHSYF and

Correlation & Price change

A.I.dvisor tells us that CHSYF and BSPK have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHSYF and BSPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
BSPK - CHSYF
9%
Poorly correlated
-27.31%
CANN - CHSYF
7%
Poorly correlated
-6.99%
CNPOF - CHSYF
5%
Poorly correlated
+3.93%
CAIHF - CHSYF
0%
Poorly correlated
N/A
CASBF - CHSYF
0%
Poorly correlated
N/A
More